Strategies for the Management of Spike Protein-Related Pathology

3Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury. This review summarizes the known treatment options for long COVID-19 and vaccine injury, their mechanisms, and their evidentiary basis.

Cite

CITATION STYLE

APA

Halma, M. T. J., Plothe, C., Marik, P., & Lawrie, T. A. (2023, May 1). Strategies for the Management of Spike Protein-Related Pathology. Microorganisms. MDPI. https://doi.org/10.3390/microorganisms11051308

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free